Recently, the National Intellectual Property Administration (CNIPA) issued the second Examination Decision on Invalidation Declaration concerning a core patent owned by Neurocentria, Inc., sustaining the patent right in its entirety. This marks another favorable ruling upholding the validity of the patent, following the first invalidation decision earlier this year.

As an innovative enterprise with significant influence in the relevant technical field, the patentee Neurocentria, Inc. has long been committed to technological R&D and intellectual property portfolio layout. As an integral part of the client’s core technology system, the stability of this patent right bears far-reaching implications for the enterprise’s market competitiveness.

In the subsequent invalidation proceeding, the Liu Shen team based its arguments on the technical substance of the patent and key points of legal application. The team systematically sorted out the technical logic and innovative aspects of the patent, and delivered rigorous responses and rebuttals to multiple grounds raised by the invalidation petitioner with supporting evidence. The Patent Reexamination and Invalidation Examination Department fully adopted the professional opinions submitted by the Liu Shen team and once again confirmed the complete validity of the patent right.

With in-depth insight into legal practice governing patent grant and validation, the Liu Shen team assisted the client in consolidating its proprietary rights amid successive invalidation challenges, effectively safeguarding the client’s independent innovation achievements and the commercial value of its intellectual property assets.

The legal team for this matter consists of LIU Guojun, JIANG Lan and WANG Wen.